期刊文献+

长效支气管扩张剂盐酸奥达特罗 被引量:2

Olodaterol hydrochloride, a long-acting bronchodilator
下载PDF
导出
摘要 盐酸奥达特罗是一种新型选择性速效、长效β2-肾上腺能受体激动剂,可迅速起效且维持24h的支气管扩张作用,全身性副作用很少。由于只需每天用药1次,故能提高患者的依从性,给以气道阻塞为特征的疾病治疗提供一种新的治疗选择。本文介绍盐酸奥达特罗的药理作用、临床研究、不良反应和与其他药物联合治疗的研究情况。 Olodaterol hydrochloride is a novel, selective, long-acting β2-adrenoceptor agonist. It has a rapid onset of action and 24-hour bronchodilator efficacy with minimal systemic pharmacodynamic effects. Since allowing once-daily administration, olodaterol hydrochloride shows an improved effect in patient compliance and provides a new choice for the treatment of obstructive pulmonary diseases. This review introduces the pharmacological action, clinical studies, adverse reaction and the combination treatments with other drugs of olodaterol hydrochloride.
出处 《上海医药》 CAS 2013年第15期19-21,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 盐酸奥达特罗 长效β2-肾上腺能受体激动剂 支气管扩张剂 olodaterol hydrochloride long-acting β2-adrenoceptor agonist bronchodilator
  • 相关文献

参考文献8

  • 1Tamura G, Ohta K. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch [J]. Respir Med, 2007, 101 (9): 1895-1902.
  • 2Bouyssou T, Casarosa P, Naline E, et al. Pharmacological characterization of olodaterol, a novel inhaled [32-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models [J]. J Pharmacol Exp Yher, 2010, 334(1): 53-62.
  • 3van Noord JA, Smeets J J, Drenth BM, et al. 24-Hour bronchodilation following a single dose of the novel 132- agonist olodaterol in COPD [J]. Pulm Pharmacol Ther, 2011, 24(6): 666-672.
  • 4Profita M, Bonanno A, Montalbano AM, et al. Long-acting 132 and anticholinergic drugs control TGF-J-mediated neutrophili inflammation in COPD [J]. Biochim Biophys Acta, 2012, 1822(7): 1079-1089.
  • 5Lamyel F, Wamken-Uhlich M, Seemann WK, et al. The 12- subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts [J]. Naunyn-Schmiedebergs Arch Pharmacol, 2011,384(2): 133-145.
  • 6Slack RJ, Barrett V J, Morrison VS, et al. In vitro pharmacological characterization of vilanterol, a novel long- acting D2-adrenoceptor agonist with 24-hour duration of action [J]. J Phannacol Exp Ther, 2013, 344(1): 218-230.
  • 7Casarosa P, Bouyssou T, Germeyer S, et al. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs [J]. J Pharmacol Exp Ther, 2009, 330(2): 660-668.
  • 8Donohue JF, Fogarty C, Lotvall J, et al. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium [J]. Am J Respir Crit Care Med, 2010 182(2): 155-162.

同被引文献11

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部